Blog

16 January, 2025

Spain, Europe’s leading country in clinical drug research

The Aemps authorised a total of 930 studies last year, making it the European regulatory agency that approved the most clinical trials, ahead of countries such […]
15 January, 2025

The global pharmaceutical industry spends almost 30% of its revenues on R&D, amounting to nearly 270 billion euros.

The International Federation of Innovative Pharmaceutical Industry publishes the Facts & Figures 2024 report, which outlines the industry’s contribution globally. In 2023, the industry filed 12,425 […]
20 December, 2024

The 10 areas that will be key to the advancement of biomedical innovation in the coming years

Pipeline Innovation Review, carried out by the consultancy firm Iqvia for the European Federation of the Pharmaceutical Industry (Efpia) and Vaccines Europe, covers biomedical research underway […]
19 December, 2024

‘Clinical trials in primary care improve patients‘ health’.

Farmaindustria and Levante-EMV hold a meeting with experts to discuss the creation of the ‘ICAP Guide’ of good practices for the promotion of clinical research in […]
17 December, 2024

The Spanish Medicines Agency authorises for the first time in Spain a phase I clinical trial under the accelerated assessment procedure

The trial, which will evaluate a vaccine under clinical investigation by GSK, will be conducted in Phase I units at La Paz, La Princesa and Puerta […]
5 December, 2024

Three keys to understanding the pharmaceutical market: sustainability, competition and pricing

The percentage of GDP that the state spends on pharmaceuticals has not increased in the last 20 years. Between 2018 and 2023, the increase in the […]
3 December, 2024

Farmaindustria highlights the ‘paradigm shift’ of AI in biomedical research

The head of Innovation and director of Innovation at Farmaindustria, Miguel González, highlighted how Artificial Intelligence (AI) has brought about a paradigm shift and a revolution […]
20 November, 2024

The impact of the innovative pharmaceutical industry in Europe: 46.2 billion euros of R&D investment and the creation of more than 2.3 million jobs

A report by PwC for the European Federation of the Pharmaceutical Industry shows that the pharmaceutical industry contributes an economic value to the EU of 311,000 […]
18 November, 2024

Public investment in medicines remains stable in terms of GDP, which reinforces the idea of long-term financial sustainability.

Farmaindustria presents ‘The pharmaceutical industry and its context in Spain 2024’, the first report that brings together in a single volume all the figures of the […]
15 November, 2024

Advances the strategy to promote clinical trials in primary care centres, which will bring new treatment opportunities to patients in Spain.

One year after the presentation of the ‘Guide of good practice recommendations for the promotion of clinical research in primary care’, promoted by Farmaindustria, successful initiatives […]
12 November, 2024

‘Good implementation of pharmacogenomic markers will optimise the use of medicines and improve health outcomes’.

Arantxa Sancho, director of the Department of Medical-Scientific Affairs at Farmaindustria, participates in the informative seminar on pharmacogenomic biomarkers organised by the Aemps. Farmaindustria.es On 29 […]
5 November, 2024

Farmaindustria connects eight research projects from Spanish universities and small companies with 15 representatives from pharmaceutical companies

The Farma-Biotech programme facilitates the efficient exchange of information and personal knowledge between research groups, small spin-off companies and the pharmaceutical industry. Since its inception in […]
31 October, 2024

Open doors for research

Farmaindustria is leading a project to bring clinical trials to primary care to help decentralise this strategy. laopiniondezamora.es ‘Transforming primary care through clinical trials’ was the […]
29 October, 2024

New report on clinical trials places Spain as a leader and success story in Europe

Assessing Europe’s clinical trial ecosystem, produced by Iqvia for Efpia and Vaccines Europe, shows a 22-12% drop in the share of studies on the continent over […]
24 October, 2024

Fina Lladós, new president of Farmaindustria: ‘I will work to generate confidence and make the industry strategic in the economic and social development of Spain’.

The Extraordinary General Assembly on Thursday unanimously elected the CEO of Amgen Iberia to lead the Association for the next two years. Source: Farmaindustria.es Fina Lladós […]
22 October, 2024

Spain advances in paediatric clinical research through international projects based on public-private partnerships

There are currently more than 600 clinical trials underway for children and adolescents in Spain, almost half of them focused on rare diseases. The Spanish Network […]
8 October, 2024

Health sector awaits upcoming regulatory changes: ‘It’s a critical time’.

The closing table of the 5th Symposium of the Healthcare Observatory reviewed the challenges facing the sector. Spain, as a leader of a European health policy’. […]
27 September, 2024

Europe streamlines access to clinical trial information

The Clinical Trials Information System (CTIS), managed by the European Medicines Agency (EMA), is a single entry point for the submission and assessment of clinical trial […]
26 September, 2024

Patient safety, a pharmaceutical industry commitment throughout the life of a medicine

From R&D to pharmacovigilance to production and incremental innovation, the industry is constantly seeking to maximise risk reduction in medicines. On World Patient Safety Day, WHO […]
24 September, 2024

Pharmaceutical companies at the forefront of adopting AI across the entire drug lifecycle

Artificial intelligence applied to medical research, top technology trend in 2024 according to the World Economic Forum.   Farmaindustria.es Artificial intelligence (AI) is a true revolution […]
19 September, 2024

The ‘Draghi Report’ recognises the pharmaceutical industry as a strategic pillar in Europe that should be strengthened.

The report highlights the sector’s contribution to the EU’s R&D and trade balance and recognises the worrying trend of Europe losing ground to other regions of […]
17 September, 2024

Innovative leadership, productive capacity and the ability to drive the country’s economic and social growth make the pharmaceutical industry an essential strategic sector.

The Director General of Farmaindustria, Juan Yermo, presents the sector’s potential and challenges on the second day of the 23rd Annual Meeting of the Pharmaceutical Industry […]
30 July, 2024

THE VALUE OF BRAND-NAME DRUGS

    1 THE BRAND-NAME DRUG COSTS THE SAME AS ITS GENERIC DRUG Farmaindustria.es Brand-name drugs are at the same price as generic drugs in Spain. The […]
23 July, 2024

The innovative pharmaceutical industry maintains its role as a leading sector in R&D investment and exports in Europe, but loses positions worldwide, surpassed by the USA and now also by China.

For the first time, China has overtaken Europe as the creator of new active ingredients, with 25 compared to the 17 of the old continent, and […]
10 July, 2024

Medicines as a strategic asset

EL PAÍS and Farmaindustria address the tasks pending to achieve autonomy in the manufacture of pharmaceuticals. Elpais.com Spain stands out for its strong pharmaceutical industry. It […]
9 July, 2024

SemFYC and Farmaindustria collaborate to promote clinical trials in Primary Care

A hundred members of the Spanish Society of Family and Community Medicine and pharmaceutical companies attend a training session to learn about the opportunities offered to […]
25 June, 2024

Farmaindustria promotes its project to increase clinical research in primary care in the autonomous communities of Spain.

After its presentation a few months ago in Andalusia, the guide to bring clinical trials to health centres has been disseminated in Castilla y León and […]
17 June, 2024

Latin American countries interested in the successful model of clinical trials in Spain promoted by Farmaindustria

The Association has participated in the Forum on clinical trials organised by the United Nations in the Latin American and Caribbean region together with the Latin […]
23 May, 2024

THESE ARE THE 10 REASONS WHY SPAIN IS A WORLD LEADER IN CLINICAL TRIALS

Spain is a benchmark country in the world and the first in Europe to conduct clinical trials to test the safety and efficacy of new drugs. […]
15 May, 2024

The European Health Technology Assessment Regulation, an opportunity to speed up access to new medicines for patients in Spain

Its application should also serve to put an end to repetitive and inefficient evaluations and guarantee rigour for patients and healthcare professionals, who will play an […]
28 January, 2020

Clinical trials, cost savings for the system and innovative therapies for the patient

They are essential to demonstrate the safety of medicines, but they also represent a significant cost savings in the health centers where they are carried out. […]